Patient-Derived Organoids of Colorectal Cancer: A Useful Tool for Personalized Medicine.

3D culture colorectal cancer patient-derived organoids personalized medicine

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
26 Apr 2022
Historique:
received: 25 03 2022
revised: 22 04 2022
accepted: 24 04 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

Colorectal cancer is one of the most important malignancies worldwide, with high incidence and mortality rates. Several studies have been conducted using two-dimensional cultured cell lines; however, these cells do not represent a study model of patient tumors very well. In recent years, advancements in three-dimensional culture methods have facilitated the establishment of patient-derived organoids, which have become indispensable for molecular biology-related studies of colorectal cancer. Patient-derived organoids are useful in both basic science and clinical practice; they can help predict the sensitivity of patients with cancer to chemotherapy and radiotherapy and provide the right treatment to the right patient. Regarding precision medicine, combining gene panel testing and organoid-based screening can increase the effectiveness of medical care. In this study, we review the development of three-dimensional culture methods and present the most recent information on the clinical application of patient-derived organoids. Moreover, we discuss the problems and future prospects of organoid-based personalized medicine.

Identifiants

pubmed: 35629118
pii: jpm12050695
doi: 10.3390/jpm12050695
pmc: PMC9147270
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 20K16175

Références

Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):713-732
pubmed: 31455888
N Engl J Med. 2018 May 31;378(22):2093-2104
pubmed: 29658845
Nature. 2006 Jan 19;439(7074):358-62
pubmed: 16273091
Br J Cancer. 2009 Aug 4;101(3):473-82
pubmed: 19603013
Cell. 2014 Sep 25;159(1):176-187
pubmed: 25201530
Cancer Sci. 2019 Apr;110(4):1480-1490
pubmed: 30742731
Sci Rep. 2021 Jun 23;11(1):13122
pubmed: 34162944
Biopreserv Biobank. 2020 Jun;18(3):222-227
pubmed: 32302515
Nat Biotechnol. 2013 Nov;31(11):1023-31
pubmed: 24142049
Cancer Res. 2012 Dec 1;72(23):6097-101
pubmed: 23172309
Cancer Cell Int. 2019 Dec 18;19:341
pubmed: 31866766
Sci Rep. 2020 Feb 21;10(1):3156
pubmed: 32081957
Food Chem Toxicol. 2002 Aug;40(8):1099-104
pubmed: 12067570
Sci Rep. 2021 Aug 26;11(1):17249
pubmed: 34446738
PLoS One. 2009 Dec 21;4(12):e8357
pubmed: 20027224
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Lab Invest. 2021 Aug;101(8):1036-1047
pubmed: 33911189
Cell Death Differ. 2018 Mar;25(3):616-633
pubmed: 29305587
Nat Protoc. 2018 Feb;13(2):235-247
pubmed: 29300390
Nat Rev Cancer. 2015 Dec;15(12):747-56
pubmed: 26536825
PLoS One. 2017 Sep 6;12(9):e0183074
pubmed: 28877221
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Exp Cell Res. 2002 May 1;275(2):185-99
pubmed: 11969289
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Exp Cell Res. 2005 Feb 15;303(2):252-62
pubmed: 15652340
Genome Med. 2020 Jan 14;12(1):8
pubmed: 31937368
Biomaterials. 2021 Sep;276:121004
pubmed: 34273688
Lancet. 2019 Oct 19;394(10207):1467-1480
pubmed: 31631858
Nat Rev Clin Oncol. 2020 Jan;17(1):11-32
pubmed: 31289352
Nature. 2011 Jul 04;476(7360):293-7
pubmed: 21727895
Micromachines (Basel). 2021 Apr 28;12(5):
pubmed: 33924829
Oncogenesis. 2013 Sep 16;2:e71
pubmed: 24042735
Proteomics. 2010 May;10(9):1886-90
pubmed: 20162561
Nat Genet. 2018 Sep;50(9):1271-1281
pubmed: 30150660
Gastroenterology. 2011 Nov;141(5):1762-72
pubmed: 21889923
Oncotarget. 2016 Jul 19;7(29):45745-45756
pubmed: 27304190
Cancer Res. 2015 May 15;75(10):2120-30
pubmed: 25808873
Nat Med. 2009 Jun;15(6):701-6
pubmed: 19398967
Br J Cancer. 2013 Apr 30;108(8):1720-31
pubmed: 23538387
J Exp Clin Cancer Res. 2021 Jun 21;40(1):198
pubmed: 34154611
J Exp Clin Cancer Res. 2021 Jun 5;40(1):185
pubmed: 34090508
J Cell Sci. 2017 Jan 1;130(1):203-218
pubmed: 27663511
iScience. 2021 May 02;24(5):102509
pubmed: 34113836
Cancer Genet Cytogenet. 1987 Jul;27(1):125-34
pubmed: 3472642
Sci Rep. 2020 Apr 27;10(1):7078
pubmed: 32341383
ESMO Open. 2021 Jun;6(3):100103
pubmed: 33887686
Nat Cancer. 2020 Jan;1(1):28-45
pubmed: 32656539
Nat Med. 2017 Jun;23(6):703-713
pubmed: 28481359
J Natl Cancer Inst. 1977 Jul;59(1):221-6
pubmed: 327080
Nat Genet. 2015 Apr;47(4):320-9
pubmed: 25706628
Cell Stem Cell. 2020 Jan 2;26(1):17-26.e6
pubmed: 31761724
Cancer Chemother Pharmacol. 2019 Aug;84(2):315-325
pubmed: 31089750
Front Oncol. 2022 Feb 11;12:841552
pubmed: 35223525
Oncodev Biol Med. 1981;2(5):355-66
pubmed: 7329817
Cancer Genet Cytogenet. 1995 Jun;81(2):103-8
pubmed: 7621404
Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):117-127
pubmed: 29360544
Cell. 2007 Aug 24;130(4):601-10
pubmed: 17719539
PLoS Genet. 2019 Mar 29;15(3):e1008076
pubmed: 30925167
Prz Gastroenterol. 2019;14(2):89-103
pubmed: 31616522
Nature. 2014 Nov 27;515(7528):568-71
pubmed: 25428505
Lancet. 2021 Aug 7;398(10299):535-554
pubmed: 34273294
Mol Cancer Ther. 2010 May;9(5):1451-60
pubmed: 20442306
Cancer Sci. 2018 Mar;109(3):507-512
pubmed: 29285848
Cancer Res. 1976 Dec;36(12):4562-9
pubmed: 1000501
Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;57(3):157-65
pubmed: 2570482
J Immunother Cancer. 2019 Mar 14;7(1):74
pubmed: 30871626
Sci Transl Med. 2019 Oct 9;11(513):
pubmed: 31597751
Cancer Med. 2020 Oct;9(20):7407-7417
pubmed: 32813918
Cell. 2015 May 7;161(4):933-45
pubmed: 25957691
Dis Colon Rectum. 2021 Jul 1;64(7):833-850
pubmed: 33709991
Mol Cell Biol. 1989 Mar;9(3):1165-72
pubmed: 2566907
Biomaterials. 2020 Dec;262:120248
pubmed: 32891909
In Vitro Cell Dev Biol Anim. 2006 Sep-Oct;42(8-9):242-7
pubmed: 17163781
JCO Precis Oncol. 2018 Nov;2:1-15
pubmed: 35135158
PLoS One. 2014 Sep 15;9(9):e107814
pubmed: 25222024
Sci Rep. 2021 Oct 29;11(1):21304
pubmed: 34716381
Mol Cancer. 2020 Jan 30;19(1):19
pubmed: 32000802
Eur J Gastroenterol Hepatol. 2001 Jul;13(7):763-70
pubmed: 11474304
Gastroenterology. 2020 Feb;158(3):638-651.e8
pubmed: 31622618
Genome Med. 2016 Oct 25;8(1):109
pubmed: 27782854
Nat Rev Immunol. 2020 Nov;20(11):651-668
pubmed: 32433532
Proc Natl Acad Sci U S A. 2019 Jul 30;116(31):15635-15644
pubmed: 31300537
Stem Cell Rev Rep. 2022 Apr;18(4):1309-1321
pubmed: 35038103
Am J Pathol. 2016 Apr;186(4):899-911
pubmed: 26878211
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2357-E2364
pubmed: 28270604
J Pathol. 2014 Sep;234(1):34-45
pubmed: 24797403
Cancer Med. 2021 Aug;10(16):5589-5598
pubmed: 34240815
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Cell Res. 2020 Aug;30(8):660-669
pubmed: 32467592
Sci Rep. 2020 Sep 4;10(1):14669
pubmed: 32887912
Nat Rev Cancer. 2005 Sep;5(9):675-88
pubmed: 16148884
J Immunother Cancer. 2019 May 6;7(1):121
pubmed: 31060602
Cells. 2019 May 28;8(6):
pubmed: 31142037
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6235-40
pubmed: 21444794
Nat Med. 2019 Oct;25(10):1607-1614
pubmed: 31591597
Mol Cancer. 2017 Jul 6;16(1):116
pubmed: 28683746
Cancer Discov. 2018 Feb;8(2):143-145
pubmed: 29431673
Cancer Discov. 2017 May;7(5):462-477
pubmed: 28331002
Front Cell Dev Biol. 2021 Oct 01;9:733270
pubmed: 34660589
N Engl J Med. 2001 Mar 15;344(11):783-92
pubmed: 11248153
Dev Dyn. 1999 Mar;214(3):239-47
pubmed: 10090150
Gut. 2020 Dec;69(12):2165-2179
pubmed: 32217638
Methods Mol Biol. 2019;1576:339-351
pubmed: 27628132
Cancer Cell. 2021 Nov 8;39(11):1531-1547.e10
pubmed: 34624218
Gut. 2019 Apr;68(4):684-692
pubmed: 29666172
Science. 2004 Mar 12;303(5664):1684-6
pubmed: 15017003
Cell Stem Cell. 2016 Jun 2;18(6):827-838
pubmed: 27212702
Nat Biotechnol. 2017 Jun;35(6):577-582
pubmed: 28459450
Nat Commun. 2020 Jul 3;11(1):3296
pubmed: 32620799
JCO Precis Oncol. 2017;2017:
pubmed: 30003184
Nat Rev Mater. 2020 Jul;5(7):539-551
pubmed: 32953138
Nat Commun. 2017 Feb 10;8:14262
pubmed: 28186126
Biomedicines. 2021 May 20;9(5):
pubmed: 34065438
Ther Adv Med Oncol. 2022 Feb 21;14:17588359221077972
pubmed: 35222695
J Biotechnol. 2010 Jul 1;148(1):3-15
pubmed: 20097238
Oncogene. 2019 Feb;38(6):780-793
pubmed: 30181548
J Biomol Screen. 2016 Oct;21(9):931-41
pubmed: 27233291
Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13308-11
pubmed: 26460009
Exp Cell Res. 1999 Jun 15;249(2):359-66
pubmed: 10366435
Lancet Oncol. 2014 Mar;15(3):323-32
pubmed: 24508103
Oncogene. 2016 Oct 6;35(40):5263-5271
pubmed: 26996663
Nat Med. 2015 Mar;21(3):256-62
pubmed: 25706875
Biochem Pharmacol. 2021 Jan;183:114354
pubmed: 33279498
Science. 2018 Feb 23;359(6378):920-926
pubmed: 29472484
Commun Biol. 2021 Dec 10;4(1):1387
pubmed: 34893703
Sci Rep. 2020 Jul 14;10(1):11574
pubmed: 32665693
J Clin Oncol. 2011 Oct 1;29(28):3753-60
pubmed: 21876084
Oncol Lett. 2021 May;21(5):406
pubmed: 33841567

Auteurs

Takumi Kiwaki (T)

Section of Oncopathology and Regenerative Biology, Department of Pathology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Miyazaki 889-1692, Japan.

Hiroaki Kataoka (H)

Section of Oncopathology and Regenerative Biology, Department of Pathology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Miyazaki 889-1692, Japan.

Classifications MeSH